The customer, a syncardia certified hospital, reported that the patient showed signs of stroke (mild aphasia and facial droop).The patient went for a head ct which was urgently followed by a cerebral thrombectomy.The customer also reported that the tah function was stable throughout and the patient¿s inr was therapeutic and as of (b)(6) 2022, the patient was fully recovered.
|
The syncardia 70cc temporary total artificial heart (tah-t) is an implantable pulsatile biventricular replacement device that replaces a patient's native ventricles and valves and pumps blood to both the pulmonary and systemic circulation systems.The syncardia 70cc tah-t is indicated for use as a bridge to transplantation in cardiac transplant-eligible candidates at risk of imminent death from biventricular failure.The syncardia tah-t system is intended for use inside and outside the hospital.Based on the provided information there is no indication of a device malfunction or performance issue of the device that would impact the reported event.Given the proximity of the onset of covid-19 infection and onset of stroke symptoms, it is possible that the covid-19 infection caused or contributed to the reported stroke.This issue will be monitored and trended as part of the customer complaint process.Syncardia has completed its evaluation and is closing this file.If new or additional information is received in the future, syncardia will file a follow-up mdr.
|